Form 4 · Filed Jul 10, 2026, 09:20 PM UTC
CTNM/Contineum Therapeutics, Inc.
Lorrain Daniel S. — Chief Scientific Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
6 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 9, 2026 | M | other | 25 | $1 | $25 | 135,227 |
| Jul 9, 2026 | S | sell | 25 | $16 | $400 | 135,202 |
| Jul 9, 2026 | M | other | 25 | — | — | 33,257 |
| Jul 8, 2026 | M | other | 1,015 | $1 | $1,025 | 136,217 |
| Jul 8, 2026 | S | sell | 1,015 | $16 | $16,240 | 135,202 |
| Jul 8, 2026 | M | other | 1,015 | — | — | 33,282 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-047909